Transplanting a genetically modified pig heart into a human chest is no longer hypothetical. Two people have received pig hearts as life-sustaining transplants (in 2022 and 2023), and baboon recipients of pig hearts have survived more than two years in preclinical studies. The procedure requires a pig whose genome has been edited with up to ten changes, a cocktail of immune-suppressing drugs unlike anything used in conventional transplants, and a surgical technique adjusted for the anatomical differences between pig and human hearts. The science behind it has been building for decades, and the gap between experimental and routine is narrowing faster than many transplant physicians expected.
Why Pigs and Not Other Animals
Early attempts at cross-species organ transplantation used primate donors. In the 1960s, chimpanzee kidneys were transplanted into patients, and the first heart transplant ever performed in a human used a chimpanzee heart in 1964, though the patient died within two hours. A baboon liver transplant in 1992 kept a patient alive for 70 days.1PubMed Central. A brief history of cross-species organ transplantation Primate donors were abandoned for several reasons: they are difficult to breed in numbers, carry viruses closely related to human pathogens, and raise serious ethical objections. Pigs emerged as the preferred alternative because they reproduce quickly, can be raised in controlled environments, and their hearts are close enough in size and function to serve as replacements in humans.
That said, pig and human hearts are not identical. Pigs walk on four legs, which means the heart sits more transversely in the chest. The great vessels leave the pig heart at different angles, and the thin-walled pulmonary artery tends to kink when placed in a human’s upright anatomy.2Journal of Surgical Research. Anatomical Study on the Surgical Technique Used for Xenotransplantation: Porcine Hearts Into Humans Inside the heart, the differences are just as real. The pig left atrium receives only two pulmonary veins where a human typically has four openings, and the muscle architecture in both ventricles is coarser, with broader internal ridges.3The Journal of Anatomy. Anatomy of the pig heart: comparisons with normal human cardiac structure These differences matter for the surgeon but have proven manageable in practice, as both clinical cases and numerous primate studies have shown.
How the Donor Pig Is Genetically Engineered
An unmodified pig heart would be destroyed by the human immune system within minutes. The body’s natural antibodies latch onto sugar molecules on pig cells and trigger a catastrophic cascade of immune attack called hyperacute rejection.4PubMed Central. Genetically modified pigs with α1,3-galactosyltransferase knockout and beyond: a comprehensive review of xenotransplantation strategies The entire modern field of pig-to-human transplantation rests on the ability to edit out the genes responsible for those sugar molecules and add human genes that calm the immune response down.
The first breakthrough was knocking out the gene for a sugar called alpha-Gal. In baboon experiments, hearts from alpha-Gal knockout pigs survived two to six months instead of minutes, with a median of about 78 days.5Nature Medicine. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience That was a dramatic improvement, but the immune system still found other pig sugars to attack. Researchers identified two more troublesome sugar-producing genes, CMAH and β4GalNT2, and knocked those out too. Cells from pigs missing all three genes showed minimal binding of human antibodies.6PubMed. Viable pigs after simultaneous inactivation of porcine MHC class I and three xenoreactive antigen genes GGTA1, CMAH and B4GALNT2 This “triple knockout” became the foundation on which further modifications are layered.
Removing the pig’s provocative sugars is only half the job. The human complement system, a network of proteins that flags and destroys foreign material, still attacks the transplant. So donor pigs are engineered to produce human complement-regulatory proteins on their cell surfaces: proteins like CD46, CD55, and CD59, which act as molecular shields telling the complement system to stand down.7PubMed Central. Complement networks in gene-edited pig xenotransplantation: enhancing transplant success and addressing organ shortage Early work with transgenic pigs carrying CD55 and CD59 showed markedly less vascular injury and longer function compared to unmodified pig hearts transplanted into baboons.8Nature Medicine. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury
Even with these changes, blood clots remained a persistent problem. Pig and human clotting systems do not communicate well, and transplanted pig hearts tended to develop dangerous clots inside the chambers and blood vessels. Adding a human gene for thrombomodulin, a protein that regulates clotting on the surface of blood vessel cells, addressed this. Donor pigs carrying the triple gene knockout plus human CD46 and human thrombomodulin showed no internal clots at 30 days after transplant, while all control hearts without thrombomodulin developed large clots that spread into the aorta and pulmonary artery.9The Journal of Heart and Lung Transplantation. Human Thrombomodulin Transgene Expression Prevents Intracardiac Thrombus in Life Supporting Pig-to-Baboon Cardiac Xenotransplantation The introduction of human coagulation-regulatory genes has been one of the biggest contributors to longer graft survival in primate studies.10PubMed Central. Overcoming Coagulation Dysregulation in Pig Solid Organ Transplantation in Nonhuman Primates: Recent Progress
The most advanced donor pigs now carry ten genetic modifications: three sugar-gene knockouts, six human transgene additions covering complement regulation, clotting regulation, and immune modulation, and one growth-related change. In primate studies, hearts from these ten-gene-edited pigs survived an average of 128 days, with one recipient making it to 225 days.11Communications Medicine. Genetically engineered pig heart transplantation in non-human primates
The Overgrowth Problem
Pig hearts grow much faster than human hearts. A pig bred for agriculture can reach several hundred pounds within a year, and its heart grows accordingly. Even a size-matched pig heart transplanted into a primate tended to keep growing inside the recipient’s chest, eventually compressing surrounding organs and failing. This was an unexpectedly stubborn obstacle. The solution came from knocking out the growth hormone receptor gene in the donor pig. Hearts from these growth-hormone-receptor knockout pigs showed minimal wall thickening over time, and baboon recipients survived up to nine months with durable heart function.12PubMed Central. The Growth of Xenotransplanted Hearts Can Be Reduced with Growth Hormone Receptor Knockout Pig Donors Using older donor pigs that have already passed their steepest growth phase further reduces this risk.13PubMed. Growth hormone receptor knockout to reduce the size of donor pigs for preclinical xenotransplantation studies
Keeping Pig Viruses Out of Humans
Transplanting a living organ from another species creates a potential highway for animal viruses to enter the human body. Two categories of infection have dominated the discussion: porcine endogenous retroviruses (PERVs) and porcine cytomegalovirus (PCMV).
PERVs are viral sequences baked into every pig’s DNA. They cannot be eliminated by clean housing alone because they are part of the pig genome itself. In 2017, researchers used CRISPR gene editing to inactivate all PERV copies in pig cells and then cloned PERV-free pigs from those cells.14PubMed Central. Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9 That achievement removed the most deep-seated viral concern, though not every donor pig line has incorporated this edit yet.
Porcine cytomegalovirus turned out to be the more immediate threat. PCMV can hide silently in a pig and reactivate after transplantation, triggering a damaging inflammatory response in the recipient. In baboon studies, transmission of PCMV during heart transplantation was associated with reduced survival time and elevated inflammatory markers.15Scientific Reports. Impact of porcine cytomegalovirus on long-term orthotopic cardiac xenotransplant survival In the first human pig heart recipient, David Bennett, reactivation of latent PCMV in the xenograft likely contributed to the graft’s deterioration.16PubMed Central. Graft dysfunction in compassionate use of genetically engineered pig-to-human cardiac xenotransplantation: a case report The lesson was clear: donor pigs must be rigorously screened and confirmed PCMV-negative before their organs are used. Facilities now use early weaning protocols and sensitive testing to ensure the virus is absent.
The Surgical Procedure
The heart transplant surgery itself resembles a standard human-to-human heart transplant, with modifications to account for the anatomical differences already described. Surgeons need to deal with the different angle at which the pig’s great vessels emerge. The pulmonary artery and the superior vena cava must be carefully oriented to avoid kinking once the heart is placed in the more vertical human chest. One unique step is ligating the left azygous vein, a vessel in pigs that drains into the coronary sinus and has no significant equivalent in human anatomy. If left open, it would create abnormal blood flow.2Journal of Surgical Research. Anatomical Study on the Surgical Technique Used for Xenotransplantation: Porcine Hearts Into Humans Size matching also requires careful attention, since a heart that is too large can compress the lungs and a heart that is too small will not pump enough blood.17PubMed Central. Anatomical Differences Between Human and Pig Hearts and Their Relevance for Cardiac Xenotransplantation Surgical Technique
How the heart is preserved between removal from the pig and implantation into the human matters enormously. Traditional cold storage with a chemical solution (cardioplegia) keeps the heart still but deprives it of oxygen. An alternative approach, cold continuous perfusion with an oxygenated solution containing nutrients and red blood cells, has shown better results in primate xenotransplant studies by preventing early graft failure.18PubMed. Cold non-ischemic heart preservation with continuous perfusion prevents early graft failure in orthotopic pig-to-baboon xenotransplantation
Immunosuppression After the Transplant
Even with ten genetic edits in the donor pig, the recipient’s immune system does not simply ignore the new heart. Strong immunosuppressive drugs are required, and the regimen differs from what human-to-human transplant recipients take. The most important drug in recent xenotransplant protocols is an anti-CD40 antibody, which blocks a signaling pathway that activates the immune cells responsible for antibody-mediated rejection.
In baboon studies, the specific antibody used and its dose made a dramatic difference. A chimeric anti-CD40 antibody given at a high dose enabled pig heart survival averaging 433 days, with the longest-surviving graft lasting 945 days, well over two and a half years. When the antibody dose was lowered or tapered off, anti-pig antibodies came roaring back and the hearts failed within weeks.19Nature Communications. Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft A different anti-CD40 antibody performed far worse, with all grafts rejecting within three to four weeks.20PubMed Central. Role of anti-CD40 antibody-mediated costimulation blockade on non-Gal antibody production and heterotopic cardiac xenograft survival in a GTKO.hCD46Tg pig-to-baboon model The takeaway is that long-term survival of a pig heart in a human probably depends on continuous, carefully dosed immunosuppression for life, much as conventional transplant recipients take daily anti-rejection medications.
What Happened in the First Two Human Cases
In January 2022, David Bennett, a 57-year-old man with terminal heart failure who was ineligible for a conventional transplant or a mechanical heart pump, received a ten-gene-edited pig heart at the University of Maryland. The heart functioned well for more than 40 days, but then anti-pig antibodies rose and his condition deteriorated. He died on day 60. Post-mortem analysis revealed that latent porcine cytomegalovirus had reactivated in the graft, likely sparking inflammation that contributed to the outcome.21PubMed Central. The first clinical pig heart transplant: Was IVIg or pig cytomegalovirus detrimental to the outcome? The cause of death remained uncertain because Bennett was already severely debilitated before surgery.21PubMed Central. The first clinical pig heart transplant: Was IVIg or pig cytomegalovirus detrimental to the outcome?
The second recipient, Lawrence Faucette, age 58, received a pig heart from the same Maryland team in September 2023. He initially made significant progress, but the heart began showing signs of rejection, and he died on October 30, 2023, about 40 days after surgery.22Journal of Thoracic Disease and Cardiothoracic Surgery. From Baby Fae to Lawrence Faucette: A Fascinating Tale of Cardiac Xenotransplantation Both cases highlighted similar challenges: finding patients who are sick enough to justify the experimental risk but healthy enough to recover, preventing PCMV activation, and managing antibody-mediated rejection.23Medicine Bulletin. Clinical Xenotransplantation of Gene‐Edited Pig Organs: A Review of Experiments in Living Humans Since 2022
How Doctors Monitor a Pig Heart After Transplant
Detecting rejection early is critical. In conventional heart transplants, doctors perform periodic heart biopsies, threading a catheter into the heart to snip tiny tissue samples. For pig heart recipients, researchers are developing less invasive options. One promising approach measures circulating pig-specific DNA in the recipient’s blood. When the transplanted heart is healthy, very little pig DNA leaks into the bloodstream. When the immune system starts attacking the graft, pig DNA levels spike, potentially giving doctors a faster and cheaper signal than a biopsy.24PubMed. Circulating pig-specific DNA as a novel biomarker for monitoring xenograft rejection This technology is still being validated, but it could eventually make post-transplant monitoring far more practical.
Preclinical Results That Paved the Way
The two human cases did not happen in a vacuum. They were preceded by decades of primate experiments that steadily pushed survival times upward. With the current best combination of genetic edits and immunosuppression, baboon recipients of pig hearts achieved consistent survival of six to nine months, a benchmark many researchers considered sufficient to justify moving to human trials.25Transplant International. Progress in Orthotopic Pig Heart Transplantation in Nonhuman Primates
More recently, a baboon study of pig hearts transplanted as a bridge to a subsequent conventional transplant showed that over half the recipients survived more than a month, six lived beyond three months, and the longest survivor lived more than 24 months. Crucially, the pig heart did not appear to sensitize the recipient’s immune system against a future human organ, meaning the pig heart could serve as a temporary bridge without ruining the chance for a permanent human transplant later.26American Journal of Transplantation. Gene-edited pig cardiac xenotransplantation as a bridge to allotransplantation in infants: Progress in a pig-to-baboon model That finding is particularly important for pediatric patients, where the wait for a size-matched human heart can be agonizingly long.
Ethics, Consent, and the Question of Who Goes First
Both human pig heart transplants were performed under the FDA’s “expanded access” (sometimes called “compassionate use”) pathway, which allows unapproved treatments for patients who have no other options. The ethical bar is high. Informed consent must cover not only the risks to the patient but also the possibility of animal viruses crossing into the human population, the intense media scrutiny that will follow, and the comparison with alternatives like mechanical heart pumps or continued waiting for a human donor.27The Annals of Thoracic Surgery. Pig-to-Human Heart Transplantation: The Ethics of Xenotransplantation
Pediatric xenotransplantation raises additional questions. Babies born with severe heart defects sometimes have no mechanical support devices small enough to keep them alive while waiting for a donor heart. Researchers are exploring FDA expanded access for these neonates, drawing on lessons from the adult cases about consent processes, long-term viral surveillance, and the protection of family members and health workers from any theoretical cross-species infections.28PubMed. Pediatric Cardiac Xenotransplantation and Expanded Access: Ethical Considerations Some patients and families may also struggle psychologically with the idea of living with an animal organ, a concern that transplant teams are expected to address during the consent process.29PubMed. Xenotransplantation: the challenge to current psychosocial attitudes
Where the Field Stands Now
The gap between what works in baboons and what works in humans has not yet been closed. The longest baboon survival exceeds two years; neither human recipient made it past two months. Part of that gap reflects patient selection: both human recipients were critically ill before surgery. Part reflects lessons still being learned about PCMV screening, immunosuppression dosing, and the subtle differences between primate and human immune responses. But the trajectory is clearly moving forward. Consistent six-to-nine-month survival in primates fulfilled the prerequisites many researchers had set for initiating formal clinical trials.25Transplant International. Progress in Orthotopic Pig Heart Transplantation in Nonhuman Primates The concept of using a pig heart as a temporary bridge, keeping a patient alive until a human heart becomes available, may reach the clinic before permanent pig-heart replacement does, given the encouraging baboon bridge-to-transplant data and the absence of immune sensitization that would complicate a later human transplant.26American Journal of Transplantation. Gene-edited pig cardiac xenotransplantation as a bridge to allotransplantation in infants: Progress in a pig-to-baboon model
For the thousands of people who die each year waiting for a donor heart, the prospect of a genetically engineered pig heart represents an option that did not exist even a decade ago. The science is real, the surgical technique is understood, and the remaining obstacles, while serious, are the kind that tend to yield to iterative clinical experience rather than requiring another conceptual breakthrough.